We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Scientific commentary reveals clinical markers of disease progression across prodromal alpha-synucleinopathy, highlighting opportunities for personalized predictive medicine.
No takes yet. Share an insight, caveat, or question.
Nepožitek et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: